PND36 Real-World Evaluation of Patients Affected By Multiple Sclerosis (MS), Relapsing-Remitting Multiple Sclerosis (RRMS) or Secondary Progressive Multiple Sclerosis (SPMS) in Italy: Prevalence, Pharmaco-Utilization and Cost Analysis